• Jobs
  • Startups
  • Hire
LoginSign up

Ratio Therapeutics

Organization banner, image 1 of 4
Organization banner, image 2 of 4
Organization banner, image 3 of 4
Organization banner, image 4 of 4

Ratio Therapeutics has 5 open roles, 1 posted in the last 30 days. Stated pay range: $70k – $200k a year. Funding stage: Series C. Last round: Jul 31, 2026.

Open roles

  • Ratio Therapeutics logo
    Chemistry Laboratory Operations Associate

    Ratio Therapeutics

    • Boston, MA
    • Junior
    • $70k–$90k
    BambooHR
    Posted 23d ago
  • Ratio Therapeutics logo
    Facilities Engineer

    Ratio Therapeutics

    • West Valley City, UT
    • Senior
    • $90k–$120k
    BambooHR
    Posted 80d ago
  • Ratio Therapeutics logo
    Scientist/Sr. Scientist, Radiopharma Development and Tech Transfer (Salt Lake City)

    Ratio Therapeutics

    • West Valley City, UT
    • Senior
    • $130k–$165k
    BambooHR
    Posted 154d ago
  • Ratio Therapeutics logo
    Associate Director, Biology

    Ratio Therapeutics

    • Boston, MA
    • Director / Executive
    • $175k–$200k
    BambooHR
    Posted 198d ago
  • Ratio Therapeutics logo
    Your Desired Role

    Ratio Therapeutics

    • Boston, MA
    BambooHR
    Posted 1395d ago

About

Ratio Therapeutics logo

Ratio Therapeutics

The Partner of Choice for Next-Generation Radiopharmaceutical Precision Medicine

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.

Private companySeries C
Founded2021
HQBoston, United States
Size
Unlock human wisdom
ThesisTermsPrivacy
11–50 employees
IndustryBiotechnology Research
Funding
  • Series C · Jul 31, 2026
Investors
Catalio Capital ManagementDuquesne Capital ManagementSchusterman Family InvestmentsBristol-Myers SquibbEli Lilly

Claim ratiotx.com

Work at ratiotx.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.